A phase II study of neoadjuvant bevacizumab and radiation therapy for resectable soft tissue sarcomas.

被引：0
|
作者：
Yoon, S. S. [1 ]
Chen, Y. [1 ]
Karl, D. [1 ]
Choy, E. [1 ]
Harmon, D. C. [1 ]
Kambadakone, A. [1 ]
Sahani, D. [1 ]
Duda, D. G. [1 ]
Jain, R. K. [1 ]
DeLaney, T. F. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.10023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10023
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE II STUDY OF NEOADJUVANT BEVACIZUMAB AND RADIOTHERAPY FOR RESECTABLE SOFT TISSUE SARCOMAS
    Yoon, Sam S.
    Duda, Dan G.
    Karl, Daniel L.
    Kim, Tae-Min
    Kambadakone, Avinash R.
    Chen, Yen-Lin
    Rothrock, Courtney
    Rosenberg, Andrew E.
    Nielsen, G. Petur
    Kirsch, David G.
    Choy, Edwin
    Harmon, David C.
    Hornicek, Francis J.
    Dreyfuss, Jonathan
    Ancukiewicz, Marek
    Sahani, Dushyant V.
    Park, Peter J.
    Jain, Rakesh K.
    DeLaney, Thomas F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 1081 - 1090
  • [2] Phase I study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcomas.
    Tseng, William W.
    Zhou, Shouhao
    Thall, Peter F.
    Lazar, Alexander J. F.
    Pollock, Raphael E.
    Lin, Patrick P.
    Cormier, Janice N.
    Feig, Barry W.
    Hunt, Kelly
    Ballo, Matthew T.
    Patel, Shreyaskumar
    Pisters, Peter W. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] A phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas.
    Agulnik, Mark
    Mohindra, Nisha Anjali
    Milhem, Mohammed M.
    Attia, Steven
    Robinson, Steven Ian
    Rademaker, Alfred
    Abbinanti, Susan E.
    Cehic, Rasima
    Humphreys, Catherine
    Prudner, Bethany
    Okuno, Scott H.
    Van Tine, Brian Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Radiation Therapy in Resectable Intrathoracic Sarcomas. A Rare Cancer Network Study
    Larsen, Francisco
    Terlizzi, Mario
    Linacre, Virginia
    Sargos, Paul
    Suarez, Francisco
    Kirova, Youlia
    Van Houtte, Paul
    Lerouge, Delphine
    Zilli, Thomas
    Sole, Claudio V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : 1175 - 1181
  • [5] A phase II consortium trial of vorinostat and bortezomib for advanced soft tissue sarcomas.
    Attia, S.
    Mahoney, M. R.
    Okuno, S. H.
    Adkins, D.
    Ahuja, H. G.
    Ducker, T. P.
    Maples, W. J.
    Ochs, L.
    Wentworth-Hartung, N. L.
    Erlichman, C.
    Bailey, H. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Systemic therapy for advanced soft-tissue sarcomas.
    Patel S.R.
    Current Oncology Reports, 2002, 4 (4) : 299 - 304
  • [7] Phase II study of anlotinib for treatment of advanced soft tissues sarcomas.
    Chi, Yihebali
    Sun, Yongkun
    Cai, Jianqiang
    Yao, Yang
    Hong, Xiaonan
    Fang, Zhiwei
    Sun, Ping
    Wang, Guowen
    Wu, Qiong
    Qu, Guofan
    Wang, Shusen
    Song, Jianmin
    Yu, Jianchun
    Lu, Yongkui
    Zhu, Xia
    Niu, Xiaohui
    He, Zhiyong
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas
    D'Adamo, DR
    Anderson, SE
    Albritton, K
    Yamada, J
    Riedel, E
    Scheu, K
    Schwartz, GK
    Chen, H
    Maki, RG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7135 - 7142
  • [9] Gemcitabine in advanced adult soft-tissue sarcomas.: A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
    Svancárová, L
    Blay, JY
    Judson, IR
    van Hoesel, QGCM
    van Oosterom, AT
    le Cesne, A
    Keizer, HJ
    Hermans, C
    van Glabbeke, M
    Verweij, J
    Hogendoorn, PCW
    Nielsen, OS
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (04) : 556 - 559
  • [10] Preoperative Radiation Therapy and IORT in Retroperitoneal Soft Tissue Sarcomas. Long Term Outcome
    Navarria, F.
    Basso, S.
    Palazzari, E.
    Innocente, R.
    Lauretta, A.
    Matrone, F.
    Fanetti, G.
    Revelant, A.
    Buonadonna, A.
    Belluco, C.
    Canzonieri, V.
    Polesel, J.
    Bertola, G.
    De Paoli, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S866 - S866
12345